See more here:
Related Post
- Human Embryonic Stem Cells Market Insights and Growth Trends: Leading Players and Future Projections to 2031 - WhaTech - September 26th, 2024
- Zac Efron says stem cell therapy helped him heal from The Iron Claw injuries - Daily Mail - September 25th, 2024
- The Role of Stem Cell Therapy in the Future of Personalized Medicine - HIT Consultant - September 25th, 2024
- Stem Cell Therapy Market to Exceed $831.9 Million by 2032 with 17.2% CAGR Growth - openPR - September 14th, 2024
- Brain Builders: How Stem Cell Research Is Rewriting the Genetic Code of Mental Health - SciTechDaily - September 14th, 2024
- Pausing biological clock could give boost to lab-produced blood stem cells - Phys.org - September 10th, 2024
- Alive and Kicking: Watch this space on controversy-free stem-cell ... - September 8th, 2024
- After 25 years of hype, embryonic stem cells still don't cure for ... - September 8th, 2024
- Human embryonic stem cells: origin, properties and applications - September 8th, 2024
- Livestock embryonic stem cells for reproductive biotechniques and ... - September 8th, 2024
- Marinexcell: Our Vision Is To Create a Sustainable and Reliable Source of Seafood Products - vegconomist - the vegan business magazine - September 6th, 2024
- How cells enter the germline at the right time and place during embryonic development - MRC Laboratory of Molecular Biology - September 6th, 2024
- Diabetes took over her life, until a stem cell therapy freed her - redlakenationnews.com - August 31st, 2024
- Diabetes took over her life, until a stem cell therapy freed her - The Washington Post - August 27th, 2024
- New way to extend shelf life of blood stem cells will improve gene therapy - University of Cambridge news - August 20th, 2024
- The anti-aging tech guy is now shooting $25,000 worth of stem cells into his knees. Here's why - Quartz - August 16th, 2024
- Substrates mimicking the blastocyst geometry revert pluripotent stem cell to naivety - Nature.com - August 12th, 2024
- Delivery of stem cell therapy for Parkinsons safe in primate trial - Parkinson's News Today - August 2nd, 2024
- Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program - July 31st, 2024
- Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024 - July 31st, 2024
- Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update - July 31st, 2024
- PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024 - July 31st, 2024
- Kymera Therapeutics to Report Second Quarter 2024 Financial Results on August 7 - July 31st, 2024
- Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2024 - July 31st, 2024
- Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline) Demonstrating No Change in In Vitro Potency... - July 31st, 2024
- Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024 - July 31st, 2024
- Appendix 4C – Q4 FY24 Quarterly Cash Flow Report - July 31st, 2024
- Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation - July 31st, 2024
- Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its... - July 31st, 2024
- Milestone® Pharmaceuticals to Present at the Upcoming BTIG Virtual Biotechnology Conference - July 31st, 2024
- Fate Therapeutics Appoints Neely Mozaffarian, MD, PhD, FACR, to its Board of Directors - July 31st, 2024
- electroCore to Announce Second Quarter June 30, 2024 Financial Results on Wednesday, August 7, 2024 - July 31st, 2024
- GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 - July 31st, 2024
- New Study: These Bizarre Blood-Sucking Fish Have a Jaw-Dropping Evolutionary Origin - SciTechDaily - July 30th, 2024
- Surgeon Turns to Stem Cells to Help Treat Autism and Immune Disorders - The Well News - July 22nd, 2024
- Study identifies epigenetic 'switches' that regulate the developmental trajectories of single cells - Medical Xpress - July 22nd, 2024
- German Man Likely 'Cured' of HIV With Stem Cell Therapy - Times Now - July 22nd, 2024
- CervoMed to Participate in the Emerging Growth Conference - July 18th, 2024
- Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives - July 18th, 2024
- Kane Biotech Receives ISO 13485:2016 MDSAP Quality Certification - July 18th, 2024
- Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of... - July 18th, 2024
- Roche’s Vabysmo showed extended durability, continued efficacy and a consistent safety profile in long-term diabetic macular edema (DME) study - July 18th, 2024
- New Nature publication confirms CARBIOS’ leadership in enzymatic degradation of plastic - July 18th, 2024
- Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion - July 18th, 2024
- Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma - July 18th, 2024
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal - July 18th, 2024
- Scorpius Holdings Announces Reverse Stock Split - July 18th, 2024
- Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines - July 18th, 2024
- Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe... - July 18th, 2024
- Q2 2024 Revenue and Business Highlights, Guidance Upgrade - July 18th, 2024
- Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line... - July 18th, 2024
- Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance - July 18th, 2024
- BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of... - July 18th, 2024
- Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and... - July 18th, 2024
- argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024 - July 18th, 2024
- Nicox Provides Second Quarter 2024 Update - July 18th, 2024
- S.BIOMEDICS Dopamine Cell Therapy for Parkinsons Disease with TED-A9 Shows Promising Results at 12 months in Phase I/IIa Clinical Trial - Morningstar - July 12th, 2024
- Induced Pluripotent Stem Cells Market Size is Expected to Grow at a CAGR of 9.4% and Reach USD 4.6 billion by 2034: Transparency Market Research Inc.... - July 12th, 2024
- Sorting therapeutic stem cells by function improves healing after heart attack, lab study shows - UCLA Newsroom - July 5th, 2024
- Stem Cell Media Market Provides An In-Depth Insight Of Sales And Trends Forecast To 2032 WBLZMedia - WBLZMedia - July 5th, 2024
- Stem Cell Banking Market is Set To Fly High in Years to Come - openPR - July 5th, 2024
- SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women - June 30th, 2024
- Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU - June 30th, 2024
- AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS - June 30th, 2024
- ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions... - June 30th, 2024
- CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition - June 30th, 2024
- Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma - June 30th, 2024
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma - June 30th, 2024
- Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day - June 30th, 2024
- 23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel - June 30th, 2024
- Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes - June 30th, 2024
- Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment - June 30th, 2024
- CHMP adopts positive opinion for BALVERSA® (erdafitinib) for the treatment of adult patients with unresectable or metastatic urothelial carcinoma... - June 30th, 2024
- Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO) - June 30th, 2024
- Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the... - June 30th, 2024
- Zealand Pharma major shareholder announcement: Van Herk Investments - June 30th, 2024
- Cell Therapy Market Booms with a CAGR of 52% by 2031 Driven by Advances in Regenerative Medicine - openPR - June 28th, 2024
- Correction: Utx Is Required for Proper Induction of Ectoderm and Mesoderm during Differentiation of Embryonic Stem ... - PLOS - June 28th, 2024
- Asia Pacific's Stem Cell Therapy Market Set to Surge with 10.29% CAGR, Reaching US$ 3,420.05 Mn by 2031 - WhaTech - June 28th, 2024
- University of Geneva Boosts Stem Cells with Glucose to Combat Osteoarthritis - India Education Diary - June 13th, 2024
Recent Comments